Found: 11
Select item for more details and to access through your institution.
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 255, doi. 10.1007/s002800000167
- By:
- Publication type:
- Article
Camptothecin analogues with enhanced antitumor activity at acidic pH.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 263, doi. 10.1007/s002800000157
- By:
- Publication type:
- Article
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 272, doi. 10.1007/s002800000153
- By:
- Publication type:
- Article
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 279, doi. 10.1007/s002800000163
- By:
- Publication type:
- Article
Selective modulation of P-glycoprotein's ATPase and anion efflux regulation activities with PKC alpha and PKC epsilon in Sf9 cells.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents.
- Published in:
- 2000
- By:
- Publication type:
- journal article
In vitro evaluation of newly developed chalcone analogues in human cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 305, doi. 10.1007/s002800000160
- By:
- Publication type:
- Article
Inhaled aerosolization of all-trans-retinoic acid for targeted pulmonary delivery.
- Published in:
- 2000
- By:
- Publication type:
- journal article
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Multiple factors other than p53 influence colon cancer sensitivity to paclitaxel.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 329, doi. 10.1007/s002800000155
- By:
- Publication type:
- Article
A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 338, doi. 10.1007/s002800000162
- By:
- Publication type:
- Article